Marvin A. Rich
- Molecular Biology top 10%
- Genetics top 5%
- Oncology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Maxwell L. EidinoffRichard L. SieglerWilliam M. VisscherLoretta CheongPhilip FurmanskiJames J. GriffinMichael J. BrennanDaniel N. Payton
- Topics
- Virus-based gene therapy research (26 papers)HIV Research and Treatment (17 papers)Hepatitis B Virus Studies (8 papers)
- Cited by
- VirologyCancer ResearchGenetics
- Journals
- NatureSciencePhysical Review Letters
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Marvin A. Rich
107 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 715
- Genetics 428
- Oncology 357
- Immunology 257
- Cancer Research 253
Countries citing papers authored by Marvin A. Rich
This map shows the geographic impact of Marvin A. Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marvin A. Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marvin A. Rich more than expected).
Fields of papers citing papers by Marvin A. Rich
This network shows the impact of papers produced by Marvin A. Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marvin A. Rich. The network helps show where Marvin A. Rich may publish in the future.
Co-authorship network of co-authors of Marvin A. Rich
This figure shows the co-authorship network connecting the top 25 collaborators of Marvin A. Rich. A scholar is included among the top collaborators of Marvin A. Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marvin A. Rich. Marvin A. Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 80 | |
| 3 | 18 | |
| 4 | 5 | |
| 5 | Understanding breast cancer : clinical and laboratory concepts | 14 |
| 6 | Cell biology of breast cancer. | 70 |
| 7 | 61 | |
| 8 | 12 | |
| 9 | 19 | |
| 10 | 43 | |
| 11 | 2 | |
| 12 | 11 | |
| 13 | 89 | |
| 14 | 2 | |
| 15 | 33 | |
| 16 | 18 | |
| 17 | 16 | |
| 18 | Growth inhibition of a human tumor cell strain by 5-fluorocytidine and 5-fluoro-2'-deoxycytidine: reversal studies. | 20 |
| 19 | Growth inhibition of a human tumor cell strain by 5-fluoro-2-deoxyuridine: time parameters for subsequent reversal by thymidine. | 57 |
| 20 | Growth inhibition of a human tumor cell strain by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine; reversal studies. | 70 |
About Marvin A. Rich
Marvin A. Rich is a scholar working on Virology, Genetics and Immunology, having authored 113 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (26 papers), HIV Research and Treatment (17 papers) and Hepatitis B Virus Studies (8 papers). The work is most often cited by research in Virology (124 citations), Cancer Research (253 citations) and Genetics (428 citations). Marvin A. Rich has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Maxwell L. Eidinoff, Richard L. Siegler, William M. Visscher, Loretta Cheong, Philip Furmanski, James J. Griffin, Michael J. Brennan, Daniel N. Payton, Catherine McGrath and M. Bolsterli. Their work appears in journals such as Nature, Science and Physical Review Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.